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Abstract
Background: Certain intestinal microflora are thought to regulate the systemic immune response. Lactic acid bacteria are
one of the most studied bacteria in terms of their beneficial effects on health and autoimmune diseases; one of which is
Multiple sclerosis (MS) which affects the central nervous system. We investigated whether the lactic acid bacterium
Pediococcus acidilactici, which comprises human commensal bacteria, has beneficial effects on experimental autoimmune
encephalomyelitis (EAE), an animal model of MS.
Methodology/Principal Findings: P. acidilactici R037 was orally administered to EAE mice to investigate the effects of R037.
R037 treatment suppressed clinical EAE severity as prophylaxis and therapy. The antigen-specific production of
inflammatory cytokines was inhibited in R037-treated mice. A significant increase in the number of CD4
+ Interleukin (IL)-
10-producing cells was observed in the mesenteric lymph nodes (MLNs) and spleens isolated from R037-treated naive mice,
while no increase was observed in the number of these cells in the lamina propria. Because only a slight increase in the
CD4
+Foxp3
+ cells was observed in MLNs, R037 may primarily induce Foxp3
2 IL10-producing T regulatory type 1 (Tr1) cells in
MLNs, which contribute to the beneficial effect of R037 on EAE.
Conclusions/Significance: An orally administered single strain of P. acidilactici R037 ameliorates EAE by inducing IL10-
producing Tr1 cells. Our findings indicate the therapeutic potential of the oral administration of R037 for treating multiple
sclerosis.
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Introduction
Multiple sclerosis (MS) is an inflammatory demyelinating
autoimmune disease of the central nervous system (CNS). The
number of patients with MS has been increasing, and MS is a
leading cause of neurological disabilities in young adults [1].
Although the pathogenesis of MS is poorly understood, various
mechanisms have been suggested by experiments utilizing
experimental autoimmune encephalomyelitis (EAE), an animal
model of MS [2]. A disturbed balance between effector and
regulatory T cells has been thought to underlie the pathogenesis of
the autoimmune inflammation of CNS [3–5]. Interleukin (IL)-17-
producing T helper cells (Th17) and interferon-c (IFN-c)-
producing T helper cells (Th1) play important roles in the
induction and propagation of EAE/MS [3]. However, IL-10-
producing regulatory T cells suppress these effector T cells. The
critical role of IL-10 in the pathogenesis of EAE is supported by
the facts that IL-10-defficient mice exhibit severe EAE, while IL-
10-transgenic mice are EAE resistant [6].
Accumulating evidence suggests that intestinal microbiota affect
systemic immune regulation. Because antigens associated with
luminal bacteria were picked up and delivered to intestinal
dendritic cells (DCs) to initiate T cell response, these microbiota
are relevant to the pathogenesis of various autoimmune diseases
[7]. In patients with inflammatory bowel disease, the subset of
intestinal microbiota is remarkably imbalanced [8]. Th17 cells
largely exist in the intestinal lamina propria (LP) in a steady state,
and microbiota play an important role in the induction of these
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cells and influence various autoimmune disease models including
an inflammatory arthritis and EAE [10–12]. IL-10-producing
CD4
+Foxp3
+ T cells and IL-10-producing CD4
+Foxp3
2 T
regulatory type 1(Tr1) cells comprise the major regulatory
populations in the small intestine, and these cells control Th17
cells in IL-10 dependent manner [13]. Recent studies have shown
that oral inoculation of indigenous Clostridium suppresses dextran
sodium sulfate-mediated colitis, a model of human inflammatory
bowel disease and increases antigen-specific IL-10 production
from splenocytes by inducing colonic regulatory T cells. This
observation implies that the alteration of intestinal microflora and
modulation of intestinal immunity could be a novel approach to
the treatment of autoimmune diseases [14].
Some lactic acid bacteria exist in human commensal
microbiota, and they have been used in food and drinks for
hundreds of years; microbial food ingredients beneficially affect
the health of the host [15]. Many studies have suggested
beneficial effects of lactic acid bacteria on various immune-
mediated diseases. For example, Lactobacillus plantarum is effective
in the colitis model, Bifidobacterium lactis and L. acidophilus in the
food allergy model, and L. casei in the arthritis model [16–18].
However, only a little information regarding the effects of lactic
acid bacteria on EAE/MS exists [19]. In the present study, we
demonstrate that oral administration of P. acidilactici induces IL-
10-producing regulatory T cells and suppresses EAE. P. acidilactici
has been used as a starter culture for fermented sausages and is
one of the human commensal bacteria [20,21]. These data
suggest that P. acidilactici can be a novel target for the treatment of
human MS.
Results
Administration of the lactic acid bacterium P. acidilactici
ameliorates EAE
We examined the effect of the lactic acid bacterium P. acidilactici
(R037) on the development of EAE. R037 (4 mg/day) and
phosphate-buffered saline (PBS) as the control were orally
administered daily to C57BL/6 mice from 14 days before
immunization with mouse myelin oligodendrocyte glycoprotein
(MOG35–55) until the end of the study. R037 treatment
significantly reduced the EAE clinical score (mean peak score,
3.660.3 vs. 4.960.3; p=0.013) (Fig. 1A; Table 1). The effect of
R037 on the development of EAE was examined using another
mouse strain because the effect of probiotics may differ with strains
[22]. SJL/J mice were treated with 0.8 mg/ml R037 or PBS in a
water bottle from 14 days before immunization with proteolipid
protein (PLP139–151) until the end of the study. Since each mouse
consumed approximately 5 ml water per day, the amount of R037
is equivalent to 4 mg/day. The suppressive effect of R037 on EAE
in SJL/J mice induced with PLP139–151 was observed again (mean
peak score, 1.560.2 vs. 2.960.4; p=0.012) (Fig. 1B; Table 1). In
addition, R037-treated SJL/J mice exhibited significantly delayed
clinical onset compared to controls (13.160.4 vs. 11.560.2;
p=0.002).
Next, we examined the pathological consequences of R037
treatment. Hematoxylin and eosin (H&E) staining of the spinal
cords obtained from C57BL/6 mice on day 22 after immunization
showed that the number of infiltrated mononuclear cells (MNCs)
in the R037 group was apparently lower than that observed in the
control group (Fig. 2A, B). The significant decrease in the number
of MNCs infiltrating the spinal cords of R037-treated mice was
confirmed by semiquantitative analysis (1.9360.26 vs. 3.1860.14;
p=0.0003) (Fig. 2C). These results suggest that prophylactic
treatment with R037 ameliorates EAE in at least two different
mice strains.
P. acidilactici inhibits the antigen-specific production of
inflammatory cytokines
To investigate the effects of R037 on systemic inflammation,
splenocytes and draining lymph node (dLN) cells harvested on
day 11 after immunization were restimulated with MOG35–55.
dLN cells obtained from R037-treated mice produced signifi-
cantly less IL-17 in response to MOG35–55 than those obtained
from the control group. The production of IFN-c decreased in
the R037-treated group although the difference was not
significant. The splenocytes obtained from the R037-treated
group produced significantly less IL-17 and IFN-c than those
obtained from the control group. The production of IL-10 by
splenocytes and dLN cells did not differ significantly between the
two groups (Fig. 3). Although we assayed IL-4 to examine the
effect of R037 treatment on Th2 skewing, the levels were below
the sensitivity of the assay system used for both groups (data not
shown). These data suggest that R037 treatment inhibits the
induction of antigen-specific encephalitogenic Th17 and Th1
cells in dLNs and spleen.
Treatment with P. acidilactici induces CD4
+ IL-10-
producing cells
To further elucidate how R037 suppressed systemic inflamma-
tion, we analyzed the cytokine profiles of C57BL/6 naive mice
treated with R037. Lamina propria lymphocyte, mesenteric lymph
node (MLN) cells and splenocytes were isolated from the mice that
were fed R037 for 2 weeks and stimulated with anti-CD3/anti-
CD28 antibodies for 72 h. Culture supernatants were examined;
no statistical difference in the production of IL-17 and IFN-c was
observed between the R037-treated and control groups. However,
a significant increase in the production of the anti-inflammatory
cytokine IL-10 was observed in MLNs and splenocytes (Fig. 4A).
These results suggest that R037 affects systemic immune
regulation. Because R037 was administered orally, we assumed
that inducible regulatory T cells (iTreg) were generated in the
intestinal LP. However, no difference in the number of CD4
+ IL-
10
+ T cells was observed between the R037-treated and control
groups. On the other hand, CD4
+ IL-10
+ T cells apparently
increased in MLNs and spleens of R037-treated mice (Fig. 4B).
Next, we examined the CD4
+Foxp3
+ cells because Foxp3
+ iTreg
cells are generated by the use of mucosal antigens [23]. No
apparent increase was observed in the number of Foxp3
+ T cells
from R037-treated mice, whereas a slight increase was observed in
MLNs. These results suggest that R037 may predominantly
induce Foxp3
2 IL-10-producing cells in MLNs.
P. acidilactici relieves EAE severity in a therapeutic
manner
Because we have demonstrated that the prophylactic adminis-
tration of R037 ameliorated EAE severity (Fig. 1), we investigated
whether the bacterium exerts a beneficial effect even after clinical
onset. Administration of R037 (0.8 mg/ml in a water bottle) to
C57BL/6 mice with EAE was started on the day of clinical onset
(day 11). Although the significant suppression assessed by mean
peak scores was not observed, the R037-treated group exhibited
milder clinical symptoms of EAE. Furthermore, the area under the
curve (AUC) during 2 to 7 days after treatment of the R037-
treated group (18.061.9) was significantly lower than that of the
control group (24.362.2; p=0.039) (Fig. 5). Thus, R037 has
therapeutic and prophylactic effects on EAE.
Beneficial Effects of P. acidilactici on EAE
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In the present study, we demonstrated that the oral adminis-
tration of the lactic acid bacterium P. acidilactici R037 induced IL-
10-producing regulatory T cells and ameliorated EAE. The
beneficial effect of R037 was demonstrated in C57BL/6 and SJL/
J mice that were immunized with MOG and PLP peptides,
respectively. In our preliminary experiments, we examined the
effects of L. delbrueckii LAB4 and P. acidilactici R037 on the
development of the collagen-induced arthritis model; only LAB4
exhibited a prophylactic effect (Tategaki, unpublished data).
However, only R037 showed a significant suppressive effect on
the EAE model in our pilot study. L. casei is beneficial in the
collagen-induced arthritis model [18] although some controversy
about its effects on EAE exists [24,25]. In addition, the efficacy of
lactic acid bacteria on EAE varied depending on the strains [19].
Taken together, these results suggest that the effects of lactic acid
bacteria on a disease model appear to depend on bacterial and/or
mice strains [22]. Cumulative evidence suggests a significant role
of IL-17 in the pathogenesis of various autoimmune diseases, and
this importance has been increasing in MS [2]. In the present
study, antigen-specific production of IL-17 and IFN-c by draining
lymph nodes and splenocytes was inhibited in the R037-treated
group, and the number of cells infiltrating the CNS decreased.
These results suggest that orally administered R037 ameliorates
EAE by suppressing systemic inflammation.
Figure 1. Pediococcus acidilactici ameliorates EAE. (A) R037 (4 mg/day; n=18) or PBS (n=17; control) was administered daily by oral gavages to
C57BL/6 mice from 14 days before immunization with MOG35–55 until the end of the study. (B) R037 (0.8 mg/ml; n=16) or PBS (n=17) in a water
bottle was administered to SJL/J mice from 14 days before immunization with PLP131–151 until the end of the study. Data represent mean score + SEM
from a representative of two independent experiments. *p#0.05; **p#0.01 (t-test).
doi:10.1371/journal.pone.0027644.g001
Table 1. Clinical scores and occurrence.
Occurrence Onset Peak score AUC
C57BL/6
R037 18/18 (100%) 13.160.6 3.660.3* 19.663.1*
control 17/17 (100%) 13.060.5 4.960.3 30.463.4
SJL/J
R037 13/16 (81%) 13.160.4** 1.560.2* 8.461.4*
control 15/17 (88%) 11.560.2 2.960.4 15.262.2
Data are reported as mean 6 SEM. The means of the peak and the area under
the curve (AUC) represent data during days 1 to 21 after immunization. Data are
representative of two independent experiments in C57BL/6 and SJL/J mice.
*p#0.05;
**p#0.01 (t-test).
doi:10.1371/journal.pone.0027644.t001
Figure 2. Infiltration of MNCs into the spinal cord is reduced in
R037-treated mice. Spinal cord sections obtained from control (A) or
R037-treated (B) C57BL/6 mice on day 22 after immunization were
analyzed by hematoxyline and eosin (H&E) staining. Scale bar=250 mm.
(C) Semiquantitative evaluation of the pathological scores was
performed as described in the Methods section. Each bar indicates
the mean pathological score + SEM of 8 mice from each group.
doi:10.1371/journal.pone.0027644.g002
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EAE by the induction of regulatory cells [26,27]. Viable P.
acidilactici could reach the intestine and produce bacteriocin, which
is an antibiotic peptide [28], because they can survive in the low
pH of gastric acid [29]. However, because R037 administered in
our study was heat-killed, it appears to be likely that cell
Figure 3. Administration of R037 inhibits the secretion of inflammatory cytokines. Lymphocytes were isolated by draining lymph nodes
(dLN) and spleens of C57BL/6 mice on day 11 after immunization and restimulating with MOG35–55 for 72 h. IL-17, IFN-c and IL-10 in the culture
supernatants were assayed by ELISA. Decreased IL-17 production by both dLN cells and splenocytes and decreased IFN-c by splenocytes were
observed in the R037-treated group. Data are shown as mean + SEM from a representative of three independent experiments for 6 mice in the R037-
treated and 8 in the control groups. **p#0.01; *p#0.05.
doi:10.1371/journal.pone.0027644.g003
Figure 4. Administration of R037 induces CD4
+ IL-10-producing T cells in mesenteric lymph nodes (MLNs) and spleen. (A) Lamina
propria cells, MLNs and splenocytes were isolated from the unimmunized mice that were fed R037 for 2 weeks and after isolation, cells were
stimulated with anti-CD3/anti-CD28 antibodies for 72 h in vitro. IL-17, interferon-c (IFN-c) and IL-10 in the supernatants were assayed by ELISA. For
lamina propria, each bar indicates mean + SEM of triplicate samples from 2 mice in each group. For MLNs and splenocytes, each bar indicates mean +
SEM of 8 mice in each group. Data are representative of more than three independent experiments for 8 mice each. * p#0.05 (B) Lamina propria cells,
MLNs and splenocytes were isolated from the mice that were fed R037 for 2 weeks. Intracellular staining of IL-10 and Foxp3 (B) in CD4
+ T cells was
analyzed by flow cytometry. Data are representative of 2 independent experiments.
doi:10.1371/journal.pone.0027644.g004
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inflammatory cytokines. The effects of bacterial components on
autoimmune diseases have been reported. Polysaccharide A from
Bacteroides fragilis is effective not only in the colitis model but also in
the EAE model [30,31]. It can induce IL-10 by CD103
+ DCs [32].
Polymannose and mannan, which are components of the bacterial
cell wall, induce IL-10 by the DCs in intestinal LP [33]. In our
study, IL-10 secretion by MLNs and splenocytes derived from
R037-treated mice significantly increased; moreover, an increase
in the number of IL-10
+ cells was confirmed. Increased IL-4
secretion by MLNs and splenocytes was not observed, while L.
paracasei increased the secretion implying Th2 skewing [19]. This
suggests that orally administered heat-killed R037 is effective on
EAE because it induces IL-10-producing cells rather than IL-4-
producing cells.
Gut-associated lymphoid tissues are thought to be the primary
site for generating iTreg cells, and CD4
+Foxp3
+ cells were the
best characterized population among these cells. Foxp3
+
regulatory T cells play important roles by inducing anti-
inflammatory IL-10-producing T cells in various autoimmune
diseases [34]. Foxp3
+ T cells induced by lactobacillus in EAE
mice are thought to be critical for the beneficial effect [19]. Other
regulatory CD4
+ T cells such as T cells expressing the latency-
associated protein (LAP) and Tr1 cells negative for Foxp3 have
been identified [35–37]. CD4
+LAP
+ T cells are induced by the
oral administration of the anti-CD3 antibody and a mixture of
probiotics [16] [38]. In the present study, CD4
+ IL-10
+ cells were
significantly increased in MLNs and spleens although
CD4
+Foxp3
+ cells were only slightly increased in MLNs and
not increased in the spleens (Fig. 4). We also stained IL-17, LAP
and NK1.1 (for invariant NKT), but only a small number of cells
were positively stained. And the number of IL-10-positive and
one of IL-17, LAP or NK1.1-positive cells were few. Therefore,
the increase of CD4
+ IL-10
+ cells was not due to an increase of
IL-10 and IL-17 double positive cells, Th3 cells, nor invariant
NKT cells. In addition, CD4
+ IL-10
+ cells did not increase in LP.
Taken together, these results suggest that R037 may not directly
induce iTreg cells in LP. Because DCs in LP migrate to MLNs by
chemokines [39], it is possible that R037 induced inhibitory DCs
in LP, which then migrated to MLN and primarily induced Tr-1
cells at least in C57BL/6 mice.
In addition to the prophylactic effect of R037 on EAE, R037
exhibited a beneficial effect when administered even after the
clinical onset of the disease. The combination of beneficial lactic
acid bacteria exhibits a synergistic effect on EAE, and viable
bacteria are more effective [19]. Because the heat-killed single
strain of R037 used in the present study was effective in both
prophylaxis and therapy, more significant effects would be
expected by using viable cells or the combination with other
beneficial bacteria. Certain lactic acid bacteria including R037
have been considered edible for a long time and exist as human
commensal microbiota [15]. It is important to investigate the
precise mechanisms of the effects of those bacteria, and
simultaneously search for more effective strains to prevent and
treat multiple sclerosis.
Materials and Methods
Animals and Reagents
Experimental procedures were approved by the Animal Care
and Use Committee of Osaka University Graduate School of
Medicine (Permit Number: 20-084-4). As the C57BL6 and SJL/J
mice are the typical two strains utilized in EAE experiment, female
6-week-old of both strains were obtained from Oriental Yeast
Corp. (Tokyo, Japan) for this study. All mice used in this study
were maintained in a specific pathogen-free environment. R037
that it is a strain of P. acidilactici was kindly provided by Kaneka
Corp. (Osaka, Japan). Since the usage of viable bacteria is
restricted in our animal facility of SPF condition, the bacteria were
centrifuged, heat-killed at 80uC for 30 min before lyophilization,
and stored in 4uC until use. In the R037 group, C57BL/6 mice
were fed 200 ml of PBS containing 20 mg/ml of heat-killed R037
daily by single oral gavage, and SJL/J mice were fed by a water
bottle containing 0.8 mg/ml heat-killed R037 from 14 days before
immunization, as oral gavage administration placed great stress on
SJL/J mice causing fatal consequences in some cases. In the
control group, 200 ml of PBS were fed for C57BL/6 mice and only
water was given in water bottle for SJL/J mice.
EAE induction and clinical score
EAE was induced using modified method we previously
described [40]. In brief, C57BL/6 mice were subcutaneously
injected with 100 mg MOG (myelin oligodendrocyte glycopro-
tein)35–55 (MEVGWYRSPFSPVVHLYRNGK) peptide emulsified
in complete Freund’s adjuvant containing 200 mgo fMycobacterium
tuberculosis H37Ra (Difco Laboratories, MI, USA), in addition to
two intraperitoneal injections of 200 ng of pertussis toxin (List
Laboratories, California, USA) on days 0 and 2. EAE in SJL/J
mice was induced by subcutaneous immunization with 200 mlo fa
complete Freund’s adjuvant containing 400 mg of H37Ra and
150 mg of PLP139–151 (HSLGKWLGHPDKF) distributed over
three sites dorsally and on the lateral hind flanks. All mice were
monitored daily for clinical signs and were scored as follows using
a scale of 0–7: 0, no signs of clinical disease; 1, paralyzed tail; 2,
paresis of hind limb and gait disturbance; 3, paralysis of one limb;
4, paralysis of two limbs; 5, two limbs paralyzed and paresis of a
third limb, but movement still possible; 6, complete forelimb
paralysis; and 7, moribund state or dead. To avoid dehydration,
mice scoring more than 5 were subcutaneously administered
0.5 ml of physiological saline solution.
Histology and semi-quantification
C57BL/6 mice were sacrificed on day 22 post immunization
followed by transcardiac perfusion with 4% paraformaldehyde in
PBS. Spinal cords were fixed in 4% paraformaldehyde in PBS and
Figure 5. R037 relieves EAE severity in a therapeutic manner.
R037 (0.8 mg/ml; n=16) or PBS (n=17; control) were administered in a
water bottle to C57BL/6 mice from 11 days after immunization with
MOG35–55. The area under the curve (AUC) under the bar was
significantly lower in R037-treated mice. Data represent mean score +
SEM of two independent experiments. *p#0.05.
doi:10.1371/journal.pone.0027644.g005
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stained with H&E. Semiquantitative histological analysis of
inflammatory cellular infiltration was performed using the
following scores: 0, no inflammation; 1, cellular infiltrates only
in the perivascular areas and meninges; 2, mild cellular infiltration
in parenchyma; 3, moderate cellular infiltrates in parenchyma;
and 4, severe cellular infiltrates in parenchyma [41].
Isolation of lymphocytes
Mesenteric lymph nodes, inguinal lymph nodes and splenocyte
were freshly harvested and homogenized. After passed through
40 mm cell strainer, splenocyte were treated with ACK lysis buffer
for 2 min. Washed with Hanks’ Balanced Salt Solutions,
centrifugated and pellet were used for lymphocytes. LP lympho-
cytes were isolated as follows [14]. Small intestines were collected
and opened longitudinally, washed to remove content, and shaken
in Hank’s balanced salt solution containing 5 mM ethylenedi-
aminetetraacetic acid for 20 min at 37uC. After removing
epithelial cells and fat tissue, the intestines were cut into small
pieces and incubated with RPMI 1640 containing 4% fetal bovine
serum, 1 mg/ml collagenase D (Roche Applied Science, India-
napolis, USA), 0.5 mg/ml dispase (Invitrogen, Carlsbad, CA), and
40 mg/ml DNase I (Roche Applied Science) for 1 h at 37uC with
shaking 110 rpm. The digested tissues were washed with Hank’s
balanced salt solution, resuspended in 5 ml of 40% Percoll (GE
Healthcare, Uppsala, Sweden), and overlaid on 2.5 ml of 80%
Percoll in a 15-ml Falcon tube. Percoll gradient separation was
performed by centrifugation at 1800 rpm for 20 min at 25uC. The
interface cells were collected and used as LP lymphocytes.
Flow cytometry
Intracellular staining of Foxp3 and IL-10, lymphocytes were
stimulated for 4 h with 50 ng/ml phorbol 12-myristate 13-acetate
(Sigma, St. Louis, MO) and 1 mg/ml ionomycin (Sigma) in the
presence of Brefeldin A (BD Biosciences, Franklin Lakes, NJ,
USA). The cells were stained for surface CD4, fixed, and
permeabilized using a BD Cytofix/Cytoperm kit, and finally
stained for intracellular IL-10 and Foxp3. The following
antibodies were used: APC-Cy7-labeled anti-CD4 (GK1.5, BD
Biosciences), Alexa647-labeled anti-Foxp3 (FJK-16s, eBioscience),
and PE-labeled anti-IL-10 (JES5-16E3, BD Biosciences) antibod-
ies. Flow cytometry was performed using a FACS Canto-2
TM with
Diva
TM software (Becton Dickinson).
Cytokine assay
For the assessment of antigen-specific cytokine production,
MNCs were isolated from draining LNs and spleens of C57BL/6
mice on day 11 after immunization with MOG35–55. Cells were
restimulated with the peptide for 72 h, and IL-17, IFN-c, IL-4,
and IL-10 were assayed by enzyme-linked immunosorbent assay
(ELISA, R&D Systems for IL-17, IFN-c, and IL-4, eBioscience for
IL-10). For the assay of cytokines produced by lymphocytes
obtained from R037-treated naive mice, MNCs from lamina
propria, MLNs and spleens were isolated from mice that were fed
R037 for 2 weeks and stimulated with coated 1 mg/ml anti-CD3
and soluble 1 mg/ml anti-CD28 antibodies for 72 h. Next, IL-17,
IFN-c, IL-4 and IL-10 were assayed by ELISA. All assays were
performed in triplicate.
Statistical analysis
Data in Figure 1A, B and Figure 5, the area under the curve
(AUC) were calculated. For statistical analysis, Data in Figure 2C,
3 and Figure 5, student’s t-test was used to calculate significant
levels. Data in Figure 4A, one way ANOVA was used to calculate
significant levels. p#0.05 was considered statistically significant.
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